1.
|
DM ParkinF BrayJ FerlayP PisaniGlobal
cancer statistics, 2002CA Cancer J
Clin5574108200510.3322/canjclin.55.2.74
|
2.
|
B LevinP BoyleWorld cancer report
2008International Agency for Research on CancerLyon3743792008
|
3.
|
H OsakaYL WangK TakadaS TakizawaR SetsuieH
LiY SatoK NishikawaYJ SunM SakuraiUbiquitin carboxy-terminal
hydrolase L1 binds to and stabilizes monoubiquitin in neuronHum Mol
Genet1219451958200310.1093/hmg/ddg21112913066
|
4.
|
R SetsuieK WadaThe functions of UCH-L1 and
its relation to neurodegenerative diseasesNeurochem
Int51105111200710.1016/j.neuint.2007.05.00717586089
|
5.
|
HJ KimYM KimS LimYK NamJ JeongHJ KimKJ
LeeUbiquitin C-terminal hydrolase-L1 is a key regulator of tumor
cell invasion and
metastasisOncogene28117127200910.1038/onc.2008.36418820707
|
6.
|
A LeiblichSS CrossJW CattoG PesceFC HamdyI
RehmanHuman prostate cancer cells express neuroendocrine cell
markers PGP 9.5 and chromogranin
AProstate6717611769200710.1002/pros.2065417929277
|
7.
|
E TezelK HibiT NagasakaA NakaoPGP9.5 as a
prognostic factor in pancreatic cancerClin Cancer
Res6476447672000
|
8.
|
L LiQ TaoH JinA van HasseltFF PoonX WangMS
ZengWH JiaYX ZengAT ChanY CaoThe tumor suppressor UCHL1 forms a
complex with p53/MDM2/ARF to promote p53 signaling and is
frequently silenced in nasopharyngeal carcinomaClin Cancer
Res1629492958201010.1158/1078-0432.CCR-09-317820395212
|
9.
|
E Okochi-TakadaK NakazawaM WakabayashiA
MoriS IchimuraT YasugiT UshijimaSilencing of the UCHL1 gene in
human colorectal and ovarian cancersInt J
Cancer11913381344200610.1002/ijc.2202516642472
|
10.
|
J YuQ TaoKF CheungH JinFF PoonX WangH LiYY
ChengC RöckenMP EbertEpigenetic identification of ubiquitin
carboxyl-terminal hydrolase L1 as a functional tumor suppressor and
biomarker for hepatocellular carcinoma and other digestive
tumorsHepatology48508518200810.1002/hep.22343
|
11.
|
DL MandelkerK YamashitaY TokumaruK
MimoriDL HowardY TanakaAL CarvalhoWW JiangHL ParkMS KimPGP9.5
promoter methylation is an independent prognostic factor for
esophageal squamous cell carcinomaCancer
Res6549634968200510.1158/0008-5472.CAN-04-392315930319
|
12.
|
Y MiyoshiS NakayamaY TorikoshiS TanakaH
IshiharaT TaguchiY TamakiS NoguchiHigh expression of ubiquitin
carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early
recurrence in patients with invasive breast cancerCancer
Sci97523529200610.1111/j.1349-7006.2006.00202.x16734731
|
13.
|
T TakaseK HibiT YamazakiH NakayamaM
TaguchiY KasaiK ItoS AkiyamaT NagasakaA NakaoPGP9.5 overexpression
in esophageal squamous cell
carcinomaHepatogastroenterology5012781280200314571718
|
14.
|
WJ WangQQ LiJD XuXX CaoHX LiF TangQ ChenJM
YangZD XuXP LiuOverexpression of ubiquitin carboxy terminal
hydrolase-L1 induces apoptosis in breast cancercellsInt J
Oncol3310371045200818949367
|
15.
|
T YamazakiK HibiT TakaseE TezelH NakayamaY
KasaiK ItoS AkiyamaT NagasakaA NakaoPGP9.5 as a marker for invasive
colorectal cancerClin Cancer Res8192195200211801558
|
16.
|
Y MaM ZhaoJ ZhongL ShiQ LuoJ LiuJ WangX
YuanC HuangProteomic profiling of proteins associated with lymph
node metastasis in colorectal cancerJ Cell
Biochem11015121519201010.1002/jcb.2272620524204
|
17.
|
CN LarsenJS PriceKD WilkinsonSubstrate
binding and catalysis by ubiquitin C-terminal hydrolases:
identification of two active
siteresiduesBiochemistry3567356744199610.1021/bi960099f8639624
|
18.
|
E HiendlmeyerS RegusS WassermannF HlubekA
HaynlA DimmlerC KochC KnollM van BeestU ReuningBeta-catenin
upregulates the expression of the urokinase plasminogen activator
in human colorectal tumorsCancer
Res6412091214200410.1158/0008-5472.CAN-3627-214973118
|
19.
|
M ShtutmanJ ZhurinskyI SimchaC AlbaneseM
D'AmicoR PestellA Ben-Ze'evThe cyclin D1 gene is a target of the
β-catenin/LEF-1 pathwayProc Natl Acad Sci USA96552255271999
|
20.
|
S FukutomiN SekiK KodaM
MiyazakiIdentification of methylation-silenced genes in colorectal
cancer cell lines genomic screening using oligonucleotide
arraysScand J
Gastroenterol4214861494200710.1080/00365520701491173
|
21.
|
Y Akishima-FukasawaY InoY NakanishiA
MiuraY MoriyaT KondoY KanaiS HirohashiSignificance of PGP9.5
expression in cancer-associated fibroblasts for prognosis of
colorectal carcinomaAm J Clin
Pathol1347179201010.1309/AJCPRJP39MIDSGBH20551269
|
22.
|
Y HongKS HoKW EuPY CheahA susceptibility
gene set for early onset colorectal cancer that integrates diverse
signaling pathway: implication for tumorigenesisClin Cancer
Res1311071114200710.1158/1078-0432.CCR-06-163317317818
|
23.
|
H MizukamiA ShirahataT GotoM SakataM
SaitoK IshibashiG KigawaH NemotoY SanadaK HibiPGP9.5 methylation as
a marker for metastatic colorectal cancerAnticancer
Res2826972700200819035297
|
24.
|
M BienzH CleversLinking colorectal cancer
to Wnt
signalingCell103311320200010.1016/S0092-8674(00)00122-711057903
|
25.
|
A BhedaW YueA GullapalliC WhitehurstR
LiuJS PaganoJ ShackelfordPositive reciprocal regulation of
ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF
signalingPLoS One4e5955200910.1371/journal.pone.000595519536331
|
26.
|
CJ SherrCancer cell
cyclesScience27416721677199610.1126/science.274.5293.16728939849
|
27.
|
S MazaudR GuyotCJ GuigonN CoudouelB Le
Magueresse-BattistoniS MagreBasal membrane remodeling during
follicle histogenesis in the rat ovary: contribution of proteinases
of the MMP and PA familiesDev
Biol277403416200510.1016/j.ydbio.2004.10.00115617683
|
28.
|
H MorganPA HillHuman breast cancer
cell-mediated bone collagen degradation requires plasminogen
activation and matrix metalloproteinase activityCancer Cell
Int51200510.1186/1475-2867-5-1
|